30:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 2f:T474,{"@context":"https://schema.org","@type":"CollectionPage","name":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials: study design Research & Clinical Takeaways","description":"Explore peer-reviewed papers on Individual Participant Data Meta-Analysis of Randomized Controlled Trials (study design). Clinician-written summaries and actionable practice insights. Updated daily.","url":"https://www.reachrx.ai/hub/tag/study_design/Individual%20Participant%20Data%20Meta-Analysis%20of%20Randomized%20Controlled%20Trials","breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.reachrx.ai"},{"@type":"ListItem","position":2,"name":"Research Hub","item":"https://www.reachrx.ai/hub"},{"@type":"ListItem","position":3,"name":"Study Designs","item":"https://www.reachrx.ai/hub/tag/study_design"},{"@type":"ListItem","position":4,"name":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials","item":"https://www.reachrx.ai/hub/tag/study_design/Individual%20Participant%20Data%20Meta-Analysis%20of%20Randomized%20Controlled%20Trials"}]}}31:Tb62,Intrauterine administration of hCG has been considered as a promising IVF add-on before embryo transfer to improve fertility outcomes. A Cochrane review and four more recent systematic reviews all showed improved clinical pregnancy rates and/or live birth rates following intrauterine administration of hCG, however, a high unexplained heterogeneity was also present. To investigate the effectiveness and safety of intrauterine administration of hCG before embryo transfer in participants undergoing IVF. Individual participant data meta-analysis (IPD-MA) is recognized as the gold standard for evidence synthesis due to its ability to harmonize the data and to investigate treatment-covariate interactions. In addition, with recent experiences of guideline development and systematic review production raising increasing concerns about the trustworthiness of randomized controlled trials (RCTs) in women's health research, an IPD-MA provides a unique opportunity to summarize the best available and most trustworthy evidence on this topic. We searched MEDLINE, Embase, Cochrane Gynaecology and Fertility Group Specialised Register, Cochrane Central Register of Controlled Trials, PsycINFO, and clinical trial registries without language restrictions up to January 2026. Inclusion criteria included RCTs comparing intrauterine administration of hCG before embryo transfer versus placebo or no intervention in participants undergoing IVF. The IPD Integrity tool and the TRACT checklist were used to evaluate the trustworthiness of studies with and without IPD, respectively. Both one-stage and two-stage random-effect IPD meta-analyses were performed with one-stage being the primary analysis. We detected 28 RCTs, of which 7 RCTs with IPD involving 2244 participants were included. All seven RCTs with IPD met trustworthiness criteria and six RCTs had overall low risk of bias. All RCTs without IPD did not meet trustworthiness criteria. IPD-MA showed intrauterine administration of hCG before embryo transfer did not improve live birth rates (7 RCTs, 2244 participants, odds ratio [OR] 0.99, 95% CI 0.83-1.19) or clinical pregnancy rates (7 RCTs, 2244 participants, OR 1.04, 95% CI 0.83-1.31). Studies without IPD showed different results from those with IPD for live birth (1.99, 0.72-5.50, P for interaction <0.001) and clinical pregnancy (1.87 (1.48-2.35), 17 RCTs without IPD, 3152 participants, P for interaction 0.005). Our IPD-MA has shown that intrauterine administration of hCG before embryo transfer is unlikely to improve the chance of clinical pregnancy and live birth. In the comparison between studies with IPD and without IPD, we found that none of the RCTs without IPD met trustworthiness criteria but showed a significant improvement in clinical pregnancy. We therefore suggest that intrauterine administration of hCG should not be offered as an IVF add-on in practice. PROSPERO (CRD42020177397).32:Tf47,Abstract BACKGROUND Intrauterine administration of hCG has been considered as a promising IVF add-on before embryo transfer to improve fertility outcomes. A Cochrane review and four more recent systematic reviews all showed improved clinical pregnancy rates and/or live birth rates following intrauterine administration of hCG, however, a high unexplained heterogeneity was also present. OBJECTIVE AND RATIONALE To investigate the effectiveness and safety of intrauterine administration of hCG before embryo transfer in participants undergoing IVF. Individual participant data meta-analysis (IPD-MA) is recognized as the gold standard for evidence synthesis due to its ability to harmonize the data and to investigate treatment–covariate interactions. In addition, with recent experiences of guideline development and systematic review production raising increasing concerns about the trustworthiness of randomized controlled trials (RCTs) in women’s health research, an IPD-MA provides a unique opportunity to summarize the best available and most trustworthy evidence on this topic. SEARCH METHODS We searched MEDLINE, Embase, Cochrane Gynaecology and Fertility Group Specialised Register, Cochrane Central Register of Controlled Trials, PsycINFO, and clinical trial registries without language restrictions up to January 2026. Inclusion criteria included RCTs comparing intrauterine administration of hCG before embryo transfer versus placebo or no intervention in participants undergoing IVF. The IPD Integrity tool and the TRACT checklist were used to evaluate the trustworthiness of studies with and without IPD, respectively. Both one-stage and two-stage random-effect IPD meta-analyses were performed with one-stage being the primary analysis. OUTCOMES We detected 28 RCTs, of which 7 RCTs with IPD involving 2244 participants were included. All seven RCTs with IPD met trustworthiness criteria and six RCTs had overall low risk of bias. All RCTs without IPD did not meet trustworthiness criteria. IPD-MA showed intrauterine administration of hCG before embryo transfer did not improve live birth rates (7 RCTs, 2244 participants, odds ratio [OR] 0.99, 95% CI 0.83–1.19) or clinical pregnancy rates (7 RCTs, 2244 participants, OR 1.04, 95% CI 0.83–1.31). Studies without IPD showed different results from those with IPD for live birth (1.99, 0.72–5.50, P for interaction <0.001) and clinical pregnancy (1.87 (1.48–2.35), 17 RCTs without IPD, 3152 participants, P for interaction 0.005). WIDER IMPLICATIONS Our IPD-MA has shown that intrauterine administration of hCG before embryo transfer is unlikely to improve the chance of clinical pregnancy and live birth. In the comparison between studies with IPD and without IPD, we found that none of the RCTs without IPD met trustworthiness criteria but showed a significant improvement in clinical pregnancy. We therefore suggest that intrauterine administration of hCG should not be offered as an IVF add-on in practice. REGISTRATION NUMBER PROSPERO (CRD42020177397). 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$2f"}}]],["$","$L30",null,{"title":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials: Research & Clinical Takeaways","description":"Browse Individual Participant Data Meta-Analysis of Randomized Controlled Trials research papers with clear, practical takeaways for your clinical practice.","papers":[{"doi":"10.1093/humupd/dmag009","pmid":"41990228","title":"Intrauterine human chorionic gonadotropin administration before embryo transfer (IHABT): an individual participant data meta-analysis of randomized controlled trials","journal_title":"Human Reproduction Update","journal_issn":"1355-4786","published_at":"2026-04-17T00:00:00.000Z","url":"https://doi.org/10.1093/humupd/dmag009","source_score":574,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2026-04-17","doi":"10.1093/humupd/dmag009","days":"30","issn":"1355-4786","rank":"1","field":"Clinical Medicine","score":"574","category":"Obstetrics & Gynecology","categories":["Obstetrics & Gynecology"],"_categories":["Obstetrics & Gynecology"]},"pubmed":{"doi":"10.1093/humupd/dmag009","title":"Intrauterine human chorionic gonadotropin administration before embryo transfer (IHABT): an individual participant data meta-analysis of randomized controlled trials.","journal":"Human reproduction update","methods":"","results":"","abstract":"$31","keywords":["clinical pregnancy","embryo transfer","human chorionic gonadotropin","individual participant data","intrauterine","live birth"],"pubmed_id":"41990228","conclusions":"","publication_date":"2026-04-17T00:00:00"},"crossref":{"DOI":"10.1093/humupd/dmag009","URL":"https://doi.org/10.1093/humupd/dmag009","ISSN":["1355-4786","1460-2369"],"link":[{"URL":"https://academic.oup.com/humupd/advance-article-pdf/doi/10.1093/humupd/dmag009/68093909/dmag009.pdf","content-type":"application/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https://academic.oup.com/humupd/advance-article-pdf/doi/10.1093/humupd/dmag009/68093909/dmag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Intrauterine human chorionic gonadotropin administration before embryo transfer (IHABT): an individual participant data meta-analysis of randomized controlled trials"],"author":[{"given":"Haowen","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University , Clayton, VIC,"}]},{"given":"Karim S","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Women’s Health Hospital, Faculty of Medicine, Assiut University , Assiut,"}]},{"given":"Barbara","family":"Wirleitner","sequence":"additional","affiliation":[{"name":"NextFertility IVF Centers Prof Zech Bregenz , Bregenz,"}]},{"given":"Kathleen H","family":"Hong","sequence":"additional","affiliation":[{"name":"IVIRMA New Jersey , Basking Ridge, NJ,"}]},{"given":"Isarin","family":"Thanaboonyawat","sequence":"additional","affiliation":[{"name":"Infertility and Reproductive Biology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok,"}]},{"given":"Pitak","family":"Laokirkkiat","sequence":"additional","affiliation":[{"name":"Infertility and Reproductive Biology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok,"}]},{"given":"Maryam","family":"Hafezi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Centre, Royan Institute for Reproductive Biomedicine , Tehran,"}]},{"given":"Shoji","family":"Kokeguchi","sequence":"additional","affiliation":[{"name":"Hanabusa Women’s Clinic , Kobe,"}]},{"given":"Ahmed","family":"Makhlouf","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Women’s Health Hospital, Faculty of Medicine, Assiut University , Assiut,"},{"name":"Faculty of Medicine, Badr University in Cairo , Cairo,"}]},{"given":"Sol","family":"Libesman","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney , Sydney, NSW,"}]},{"given":"David","family":"Nguyen","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney , Sydney, NSW,"}]},{"given":"Jonathan G","family":"Williams","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney , Sydney, NSW,"}]},{"given":"Marian","family":"Showell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Auckland , Auckland,"}]},{"given":"Moustafa","family":"Gadalla","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Women’s Health Hospital, Faculty of Medicine, Assiut University , Assiut,"}]},{"given":"Ben W J","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University , Clayton, VIC,"},{"name":"Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre , Amsterdam,"}]},{"given":"Wentao","family":"Li","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology and Statistics Unit, Centre for Big Data Research in Health, The University of New South Wales , Sydney, NSW,"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney , Sydney, NSW,"}]}],"funder":[{"name":"Monash Research Scholarship and PhD Top-up Scholarship via the Centre for Research Excellence in Women’s Health in Reproductive Life","award":["App1171592"],"award-info":[{"award-number":["App1171592"]}]},{"name":"National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant","award":["2009767"],"award-info":[{"award-number":["2009767"]}]}],"issued":{"date-parts":[[2026,4,16]]},"member":"286","prefix":"10.1093","source":"Crossref","volume":null,"created":{"date-time":"2026-03-28T12:45:24Z","timestamp":1774701924000,"date-parts":[[2026,3,28]]},"indexed":{"date-time":"2026-04-16T20:00:27Z","timestamp":1776369627937,"date-parts":[[2026,4,16]]},"license":[{"URL":"https://creativecommons.org/licenses/by/4.0/","start":{"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000,"date-parts":[[2026,4,16]]},"delay-in-days":0,"content-version":"vor"}],"subject":[],"abstract":"$32","language":"en","relation":{},"resource":{"primary":{"URL":"https://academic.oup.com/humupd/advance-article/doi/10.1093/humupd/dmag009/8656006"}},"subtitle":[],"deposited":{"date-time":"2026-04-16T19:04:35Z","timestamp":1776366275000,"date-parts":[[2026,4,16]]},"issn-type":[{"type":"print","value":"1355-4786"},{"type":"electronic","value":"1460-2369"}],"published":{"date-parts":[[2026,4,16]]},"publisher":"Oxford University Press (OUP)","reference":[{"DOI":"10.1016/j.rbmo.2021.06.011","key":"2026041615041990300_dmag009-B1","year":"2021","issue":null,"author":"Abdallah","volume":"43","first-page":"663","unstructured":null,"article-title":"Intrauterine injection of HCG before embryo transfer: a parallel, double-blind randomized trial","journal-title":"Reprod Biomed Online","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026041615041990300_dmag009-B2","year":"2023","issue":null,"author":"Adamson","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1093/humupd/dmaa031","key":"2026041615041990300_dmag009-B3","year":"2020","issue":null,"author":"Bordewijk","volume":"26","first-page":"929","unstructured":null,"article-title":"To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome?","journal-title":"Hum Reprod Update","doi-asserted-by":"crossref"},{"DOI":"10.1002/sim.7141","key":"2026041615041990300_dmag009-B4","year":"2017","issue":null,"author":"Burke","volume":"36","first-page":"855","unstructured":null,"article-title":"Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ","journal-title":"Stat Med","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026041615041990300_dmag009-B5","year":"2018","issue":null,"author":"Craciunas","volume":"10","first-page":"CD011537","unstructured":null,"article-title":"Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction","journal-title":"Cochrane Database Syst Rev","doi-asserted-by":null},{"DOI":"10.1093/humrep/deaa241","key":"2026041615041990300_dmag009-B6","year":"2020","issue":null,"author":"Duffy","volume":"35","first-page":"2725","unstructured":null,"article-title":"Developing a core outcome set for future infertility research: an international consensus development study","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1016/S0140-6736(21)00217-8","key":"2026041615041990300_dmag009-B7","year":"2021","issue":null,"author":"EPPPIC","volume":"397","first-page":"1183","unstructured":null,"article-title":"Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials","journal-title":"Lancet","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.fertnstert.2019.02.027","key":"2026041615041990300_dmag009-B8","year":"2019","issue":null,"author":"Gao","volume":"112","first-page":"89","unstructured":null,"article-title":"Intrauterine injection of human chorionic gonadotropin before embryo transfer can improve in vitro fertilization-embryo transfer outcomes: a meta-analysis of randomized controlled trials","journal-title":"Fertil Steril","doi-asserted-by":"crossref"},{"DOI":"10.1002/jrsm.1590","key":"2026041615041990300_dmag009-B9","year":"2023","issue":null,"author":"Godolphin","volume":"14","first-page":"68","unstructured":null,"article-title":"Estimating interactions and subgroup-specific treatment effects in meta-analysis without aggregation bias: a within-trial framework","journal-title":"Res Synth Methods","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jclinepi.2010.04.026","key":"2026041615041990300_dmag009-B10","year":"2011","issue":null,"author":"Guyatt","volume":"64","first-page":"383","unstructured":null,"article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","journal-title":"J Clin Epidemiol","doi-asserted-by":"crossref"},{"DOI":"10.1007/s00404-018-4752-2","key":"2026041615041990300_dmag009-B11","year":"2018","issue":null,"author":"Hafezi","volume":"297","first-page":"1571","unstructured":null,"article-title":"The effect of intrauterine human chorionic gonadotropin flushing on live birth rate after vitrified-warmed embryo transfer in programmed cycles: a randomized clinical trial","journal-title":"Arch Gynecol Obstet","doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/dex004","key":"2026041615041990300_dmag009-B12","year":"2017","issue":null,"author":"Harper","volume":"32","first-page":"485","unstructured":null,"article-title":"Adjuncts in the IVF laboratory: where is the evidence for ‘add-on’ interventions?","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1136/bmj.i6295","key":"2026041615041990300_dmag009-B13","year":"2016","issue":null,"author":"Heneghan","volume":"355","first-page":"i6295","unstructured":null,"article-title":"Lack of evidence for interventions offered in UK fertility centres","journal-title":"BMJ","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.fertnstert.2014.08.006","key":"2026041615041990300_dmag009-B14","year":"2014","issue":null,"author":"Hong","volume":"102","first-page":"1591","unstructured":null,"article-title":"Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double-blind, placebo-controlled trial","journal-title":"Fertil Steril","doi-asserted-by":"crossref"},{"DOI":"10.1007/s00404-018-4923-1","key":"2026041615041990300_dmag009-B15","year":"2018","issue":null,"author":"Hou","volume":"298","first-page":"1061","unstructured":null,"article-title":"Effect of intrauterine injection of human chorionic gonadotropin before fresh embryo transfer on IVF and ICSI outcomes: a meta-analysis","journal-title":"Arch Gynecol Obstet","doi-asserted-by":"crossref"},{"DOI":"10.1002/jrsm.1738","key":"2026041615041990300_dmag009-B16","year":"2024","issue":null,"author":"Hunter","volume":"15","first-page":"917","unstructured":null,"article-title":"The Individual Participant Data Integrity Tool for assessing the integrity of randomised trials","journal-title":"Res Synth Methods","doi-asserted-by":"crossref"},{"DOI":"10.4049/jimmunol.171.5.2305","key":"2026041615041990300_dmag009-B17","year":"2003","issue":null,"author":"Kayisli","volume":"171","first-page":"2305","unstructured":null,"article-title":"Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system","journal-title":"J Immunol","doi-asserted-by":"crossref"},{"DOI":"10.1016/S0140-6736(23)00168-X","key":"2026041615041990300_dmag009-B18","year":"2023","issue":null,"author":"Kieslinger","volume":"401","first-page":"1438","unstructured":null,"article-title":"Clinical outcomes of uninterrupted embryo culture with or without time-lapse-based embryo selection versus interrupted standard culture (SelecTIMO): a three-armed, multicentre, double-blind, randomised controlled trial","journal-title":"Lancet","doi-asserted-by":"crossref"},{"DOI":"10.1007/s00404-018-4962-7","key":"2026041615041990300_dmag009-B19","year":"2019","issue":null,"author":"Laokirkkiat","volume":"299","first-page":"267","unstructured":null,"article-title":"Increased implantation rate after intrauterine infusion of a small volume of human chorionic gonadotropin at the time of embryo transfer: a randomized, double-blind controlled study","journal-title":"Arch Gynecol Obstet","doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/deab098","key":"2026041615041990300_dmag009-B20","year":"2021","issue":null,"author":"Lensen","volume":"36","first-page":"1854","unstructured":null,"article-title":"How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/dead184","key":"2026041615041990300_dmag009-B21","year":"2023","issue":null,"author":"Lundin","volume":"38","first-page":"2062","unstructured":null,"article-title":"Good practice recommendations on add-ons in reproductive medicine","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.fertnstert.2015.07.351","key":"2026041615041990300_dmag009-B22","year":"2015","issue":null,"author":"Matsumoto","volume":"104","first-page":"e114","unstructured":null,"article-title":"Systemic or local human chorionic gonadotropin administration is not beneficial for frozen-thawed embryo transfer in hormone replacement cycles: two prospective randomized trials","journal-title":"Fertil Steril","doi-asserted-by":"crossref"},{"DOI":"10.1186/s41073-023-00130-8","key":"2026041615041990300_dmag009-B23","year":"2023","issue":null,"author":"Mol","volume":"8","first-page":"6","unstructured":null,"article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","journal-title":"Res Integr Peer Rev","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.eclinm.2024.102717","key":"2026041615041990300_dmag009-B24","year":"2024","issue":null,"author":"Mousa","volume":"74","first-page":"102717","unstructured":null,"article-title":"Research Integrity in Guidelines and evIDence synthesis (RIGID): a framework for assessing research integrity in guideline development and evidence synthesis","journal-title":"EClinicalMedicine","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026041615041990300_dmag009-B25","year":"2023","issue":null,"author":"Newman","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1016/j.ijsu.2021.105906","key":"2026041615041990300_dmag009-B26","year":"2021","issue":null,"author":"Page","volume":"88","first-page":"105906","unstructured":null,"article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","journal-title":"Int J Surg","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.eclinm.2025.103346","key":"2026041615041990300_dmag009-B27","year":"2025","issue":null,"author":"Patabendige","volume":"85","first-page":"103346","unstructured":null,"article-title":"Data-sharing and trustworthiness of trials evaluating cervical ripening in induction of labour: a meta-epidemiological study of randomised controlled trials","journal-title":"EClinicalMedicine","doi-asserted-by":"crossref"},{"DOI":"10.1177/1933719114522553","key":"2026041615041990300_dmag009-B28","year":"2014","issue":null,"author":"Racicot","volume":"21","first-page":"1274","unstructured":null,"article-title":"Human chorionic gonadotropin enhances trophoblast-epithelial interaction in an in vitro model of human implantation","journal-title":"Reprod Sci","doi-asserted-by":"crossref"},{"DOI":"10.1002/sim.8516","key":"2026041615041990300_dmag009-B29","year":"2020","issue":null,"author":"Riley","volume":"39","first-page":"2115","unstructured":null,"article-title":"Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning","journal-title":"Stat Med","doi-asserted-by":"crossref"},{"DOI":"10.1002/9781119333784","key":"2026041615041990300_dmag009-B30","year":"2021","issue":null,"author":"Riley","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/14.Suppl_3.180-a","key":"2026041615041990300_dmag009-B31","year":"1999","issue":null,"author":"Rubinstein","volume":"14","first-page":"180","unstructured":null,"article-title":"P-080. Oocyte donation programme: influence of age and aetiology and improvement of uterine blood flow velocity and pregnancy outcome after low-dose aspirin treatment","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/dead197","key":"2026041615041990300_dmag009-B32","year":"2023","issue":null,"author":"Smeenk","volume":"38","first-page":"2321","unstructured":null,"article-title":"ART in Europe, 2019: results generated from European registries by ESHRE","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1136/bmjopen-2016-013940","key":"2026041615041990300_dmag009-B33","year":"2016","issue":null,"author":"Spencer","volume":"6","first-page":"e013940","unstructured":null,"article-title":"Claims for fertility interventions: a systematic assessment of statements on UK fertility centre websites","journal-title":"BMJ Open","doi-asserted-by":"crossref"},{"DOI":"10.1136/bmj.l4898","key":"2026041615041990300_dmag009-B34","year":"2019","issue":null,"author":"Sterne","volume":"366","first-page":"l4898","unstructured":null,"article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","journal-title":"BMJ","doi-asserted-by":"crossref"},{"DOI":"10.1001/jama.2015.3656","key":"2026041615041990300_dmag009-B35","year":"2015","issue":null,"author":"Stewart","volume":"313","first-page":"1657","unstructured":null,"article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement","journal-title":"JAMA","doi-asserted-by":"crossref"},{"DOI":"10.1055/a-0837-3246","key":"2026041615041990300_dmag009-B36","year":"2019","issue":null,"author":"Tan","volume":"79","first-page":"713","unstructured":null,"article-title":"The effect of intrauterine administration of human chorionic gonadotropin (hCG) before embryo transfer during assisted reproductive cycles: a meta-analysis of randomized controlled trials","journal-title":"Geburtshilfe Frauenheilkd","doi-asserted-by":"crossref"},{"DOI":"10.1186/1471-2288-14-79","key":"2026041615041990300_dmag009-B37","year":"2014","issue":null,"author":"Thomas","volume":"14","first-page":"79","unstructured":null,"article-title":"Systematic review of methods for individual patient data meta-analysis with binary outcomes","journal-title":"BMC Med Res Methodol","doi-asserted-by":"crossref"},{"DOI":"10.1371/journal.pmed.1001855","key":"2026041615041990300_dmag009-B38","year":"2015","issue":null,"author":"Tierney","volume":"12","first-page":"e1001855","unstructured":null,"article-title":"Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use","journal-title":"PLoS Med","doi-asserted-by":"crossref"},{"DOI":"10.1093/humupd/dmac009","key":"2026041615041990300_dmag009-B39","year":"2022","issue":null,"author":"Tyler","volume":"28","first-page":"480","unstructured":null,"article-title":"Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses","journal-title":"Hum Reprod Update","doi-asserted-by":"crossref"},{"DOI":"10.1093/humrep/deaf064","key":"2026041615041990300_dmag009-B40","year":"2025","issue":null,"author":"Wang","volume":"40","first-page":"785","unstructured":null,"article-title":"‘And Then There Were None’—the shrinkage of trials in the evidence ecosystem","journal-title":"Hum Reprod","doi-asserted-by":"crossref"},{"DOI":"10.1093/humupd/dmz029","key":"2026041615041990300_dmag009-B41","year":"2019","issue":null,"author":"Wang","volume":"25","first-page":"717","unstructured":null,"article-title":"First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis","journal-title":"Hum Reprod Update","doi-asserted-by":"crossref"},{"DOI":"10.1093/humupd/dmac021","key":"2026041615041990300_dmag009-B42","year":"2022","issue":null,"author":"Wessel","volume":"28","first-page":"733","unstructured":null,"article-title":"Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis","journal-title":"Hum Reprod Update","doi-asserted-by":"crossref"},{"DOI":"10.1186/s12958-015-0069-1","key":"2026041615041990300_dmag009-B43","year":"2015","issue":null,"author":null,"volume":"13","first-page":"70","unstructured":null,"article-title":"Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study","journal-title":"Reprod Biol Endocrinol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ejogrb.2019.10.039","key":"2026041615041990300_dmag009-B44","year":"2019","issue":null,"author":"Xie","volume":"243","first-page":"133","unstructured":null,"article-title":"Effect of intrauterine perfusion of human chorionic gonadotropin before embryo transfer after two or more implantation failures: a systematic review and meta-analysis","journal-title":"Eur J Obstet Gynecol Reprod Biol","doi-asserted-by":"crossref"}],"short-title":[],"article-number":"dmag009","content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["Human Reproduction Update"],"reference-count":44,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2026,4,16]]},"references-count":44,"short-container-title":[],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1093/humupd/dmag009","is_oa":true,"title":"Intrauterine human chorionic gonadotropin administration before embryo transfer (IHABT): an individual participant data meta-analysis of randomized controlled trials","updated":"2026-04-17T18:33:20+00:00","published_date":"2026-03-28","best_oa_location":{"url":"https://doi.org/10.1093/humupd/dmag009","pmh_id":null,"url_for_pdf":null,"url_for_landing_page":"https://doi.org/10.1093/humupd/dmag009"}}},"created_at":"2026-05-07T22:50:41.366Z","updated_at":"2026-05-14T15:13:26.918Z","tags":[{"paper_doi":"10.1093/humupd/dmag009","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"category","value":"Obstetrics & Gynecology","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"condition","value":"Infertility","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"condition","value":"In Vitro Fertilization","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"generic","value":"chorionic gonadotropin","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"impact_flag","value":"practice_changing","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"level_of_evidence","value":"1","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"modality","value":"Intrauterine hCG Administration","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"sample_size","value":"n=2244","value_numeric":2244},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"sex","value":"female","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"study_design","value":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"warning","value":"Only 7 of 28 eligible RCTs contributed IPD; the 21 excluded trials all failed trustworthiness criteria, so findings represent a selected but high-integrity subset of available evidence.","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"warning","value":"The brand name of the hCG product(s) used across trials is not specified in the abstract; formulations may vary across included RCTs.","value_numeric":null},{"paper_doi":"10.1093/humupd/dmag009","tag_type":"warning","value":"The impact_flag 'practice_changing' was applied because the IPD-MA directly contradicts prior positive systematic reviews and the authors explicitly recommend against clinical use — but this is a recommendation to stop, not to start, a practice.","value_numeric":null}],"summaries":{"practice_takeaway":"Intrauterine hCG should **not** be offered as an IVF add-on — trustworthy IPD from 7 RCTs shows no benefit on live birth or clinical pregnancy. Clinicians should be cautious when prior positive evidence came exclusively from trials that failed data integrity checks.","key_result":"Intrauterine hCG did **not** improve live birth rates (OR 0.99, 95% CI 0.83–1.19) or clinical pregnancy rates (OR 1.04, 95% CI 0.83–1.31). Notably, 17 RCTs excluded for lacking IPD failed trustworthiness criteria yet showed apparent benefit (clinical pregnancy OR 1.87, 95% CI 1.48–2.35; P for interaction = 0.005), suggesting prior positive results were likely driven by untrustworthy trial data.","what_studied":"This IPD meta-analysis of 7 RCTs (2,244 participants) evaluated whether intrauterine hCG administration before embryo transfer improves live birth or clinical pregnancy rates in IVF, compared to placebo or no intervention.","limitations":"Only 7 of 28 identified RCTs provided IPD, meaning most available trial data could not be verified and were excluded. Subgroup analyses for potential treatment-covariate interactions may have been underpowered at n=2,244."}}],"initialOffset":1,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"study_design","value":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Study Designs","href":"/hub/tag/study_design"},{"name":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"study_design","hub_tag_value":"Individual Participant Data Meta-Analysis of Randomized Controlled Trials"}}}]]

Papers